SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-4.9%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.47B
AUM Growth
+$2.47B
(-8.5%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
112
New
16
Increased
28
Reduced
14
Closed
11
Top Buys
| 1 |
Home Depot
HD
|
$35.8M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$31.6M |
| 3 |
Bank of America
BAC
|
$31.5M |
| 4 |
89bio
ETNB
|
$30M |
| 5 |
Chipotle Mexican Grill
CMG
|
$27.1M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$97.4M |
| 2 |
Coca-Cola
KO
|
$51.7M |
| 3 |
Starbucks
SBUX
|
$47M |
| 4 |
CRH
CRH
|
$37.2M |
| 5 |
McDonald's
MCD
|
$30M |
Sector Composition
| 1 | Healthcare | 65.45% |
| 2 | Technology | 11.42% |
| 3 | Consumer Discretionary | 7.21% |
| 4 | Financials | 5.81% |
| 5 | Communication Services | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tesla
TSLA
$1.08T
| $31.6M | 1.17% | 122,016 -41,614 | -25% | -$10.8M |
|
|
27
Bank of America
BAC
$376B
| $31.5M | 1.17% | +753,913 | New | +$31.5M |
|
|
28
Coca-Cola
KO
$297B
| $29.8M | 1.1% | 415,720 -722,133 | -63% | -$51.7M |
|
|
29
Chipotle Mexican Grill
CMG
$56.5B
| $27.1M | 1.01% | +539,540 | New | +$27.1M |
|
30
Mineralys Therapeutics
MLYS
$1.03B
| $26.5M | 0.98% | +1,667,759 | New | +$26.5M |
|
31
Boston Scientific
BSX
$156B
| $26.4M | 0.98% | 262,099 -135,580 | -34% | -$13.7M |
|
32
United Airlines
UAL
$34B
| $25.3M | 0.94% | 366,375 +165,725 | +83% | +$11.4M |
|
33
Rocket Pharmaceuticals
RCKT
$354M
| $23.4M | 0.87% | 3,502,000 +935,049 | +36% | +$6.24M |
|
34
Ferguson
FERG
$46.4B
| $20.8M | 0.77% | 129,924 -115,606 | -47% | -$18.5M |
|
35
Snowflake
SNOW
$79.6B
| $20.2M | 0.75% | +137,886 | New | +$20.2M |
|
36
Arcus Biosciences
RCUS
$1.13B
| $20.1M | 0.75% | 2,560,904 +1,984,748 | +344% | +$15.6M |
|
|
PVLA
37
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $20M | 0.74% | 714,463 | – | – |
|
38
Datadog
DDOG
$47.7B
| $18.2M | 0.67% | 183,231 +6,781 | +4% | +$673K |
|
39
Johnson & Johnson
JNJ
$427B
| $18.1M | 0.67% | 109,386 -30,600 | -22% | -$5.07M |
|
40
Abeona Therapeutics
ABEO
$350M
| $17.5M | 0.65% | 3,685,503 | – | – |
|
41
Erasca
ERAS
$445M
| $16.9M | 0.63% | 12,315,004 | – | – |
|
42
Biogen
BIIB
$19.4B
| $16.5M | 0.61% | 120,736 +5,300 | +5% | +$725K |
|
43
Caesars Entertainment
CZR
$5.57B
| $16.3M | 0.61% | 652,493 -119,919 | -16% | -$3M |
|
44
Aura Biosciences
AURA
$389M
| $16M | 0.59% | +2,731,886 | New | +$16M |
|
45
UnitedHealth
UNH
$281B
| $15.7M | 0.58% | 29,900 -45,298 | -60% | -$23.7M |
|
46
Take-Two Interactive
TTWO
$43B
| $15M | 0.56% | +72,400 | New | +$15M |
|
47
Moderna
MRNA
$9.37B
| $14.7M | 0.54% | +517,163 | New | +$14.7M |
|
48
Fulcrum Therapeutics
FULC
$351M
| $14.6M | 0.54% | 5,067,394 +1,728,928 | +52% | +$4.98M |
|
49
Goldman Sachs
GS
$226B
| $14M | 0.52% | 25,538 -48,660 | -66% | -$26.6M |
|
50
Roblox
RBLX
$86.4B
| $13.3M | 0.49% | +227,710 | New | +$13.3M |
|